Previous studies showed that either LIN28 or FGFR1 is strongly correlated with the progression of NSCLC,22, 27 and FGFR1 inhibitors achieved a definite therapeutic effect of NSCLC in the clinic and in an animal model.30, 31, 34. Here, FGFR1 is linked to non-small cell lung carcinoma.